Dr. Heidi Overton, President Donald Trump’s nominee to head the Food and Drug Administration (FDA), participated in a Senate hearing on Thursday. The session was marked by attempts from lawmakers to clarify her positions on high-profile public health issues, specifically vaccines and abortion access.

According to reports from The Hill, Overton maintained a cautious approach throughout the proceedings. When pressed by senators on these sensitive topics, the nominee opted to sidestep direct answers, choosing instead to navigate the questioning without committing to specific policy stances. The hearing highlighted the tension between the administration's choice for the agency and the expectations of lawmakers seeking clear policy commitments. While the nominee’s performance was characterized as evasive by some observers, the hearing served as a formal introduction of her priorities to the legislative body tasked with her confirmation. No further details regarding specific exchanges or the reactions of individual senators were provided in the initial reporting.